Werner Milton H. 13D and 13G filings for Inhibikase Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-15 7:45 pm Purchase |
2022-12-31 | 13G | Inhibikase Therapeutics, Inc. IKT |
Werner Milton H. | 926,485 19.680% |
16,812 (+1.85%) |
Filing |
| 2022-02-11 5:15 pm Purchase |
2021-12-31 | 13G | Inhibikase Therapeutics, Inc. IKT |
Werner Milton H. | 909,673 21.700% |
2,736 (+0.30%) |
Filing |
| 2021-02-11 4:06 pm Purchase |
2020-12-22 | 13G | Inhibikase Therapeutics, Inc. IKT |
Werner Milton H. | 906,937 53.100% |
906,937 (New Position) |
Filing |